Company intelligence / Profile preview

Flow Therapy

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Flow Therapy offers EECP, a non-invasive, device-based therapy for angina, heart failure, and other cardiac conditions, with benefits including improved quality of life, reduced angina episodes, and decreased rehospitalization rates, supported by more than 430 peer-reviewed publications and broad insurance coverage. The company operates specialized outpatient centers for delivering the therapy to patients refractory to or unsuitable for other treatments.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Flow Therapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flow Therapy.

Explore the full profile